Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke
Omecamtiv mecarbil (OM) is a positive cardiac inotrope in clinical trials for the treatment of heart failure whose mechanism of action is incompletely understood. Here the authors show that OM inhibits myosin's working stroke and prolongs actomyosin attachment and propose a model that reconcile...
Guardado en:
Autores principales: | Michael S. Woody, Michael J. Greenberg, Bipasha Barua, Donald A. Winkelmann, Yale E. Goldman, E. Michael Ostap |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a390d9a0840145559f69f13c5f0635e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
por: Vicente J. Planelles-Herrero, et al.
Publicado: (2017) -
Orthophosphate increases the efficiency of slow muscle-myosin isoform in the presence of omecamtiv mecarbil
por: Serena Governali, et al.
Publicado: (2020) -
Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model
por: Ashit Trivedi, et al.
Publicado: (2021) -
Cardiac myosin binding protein C, adrenergic stimulation and cardiac contractility
por: Amsha Ramburan, et al.
Publicado: (2017) -
Cerebral effects of commonly used vasopressor-inotropes: a study in newborn piglets.
por: Gitte H Hahn, et al.
Publicado: (2013)